[HTML][HTML] Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities

ED Mock, B Gagestein, M van der Stelt - Progress in Lipid Research, 2023 - Elsevier
Abstract N-acylethanolamines (NAEs), including N-palmitoylethanolamine (PEA), N-
oleoylethanolamine (OEA), N-arachidonoylethanolamine (AEA, anandamide), N …

Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies

DP Finn, S Haroutounian, AG Hohmann, E Krane… - Pain, 2021 - journals.lww.com
This narrative review represents an output from the International Association for the Study of
Pain's global task force on the use of cannabis, cannabinoids, and cannabis-based …

Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory …

D Haspula, MA Clark - International journal of molecular sciences, 2020 - mdpi.com
The identification of the human cannabinoid receptors and their roles in health and disease,
has been one of the most significant biochemical and pharmacological advancements to …

The molecular logic of endocannabinoid signalling

D Piomelli - Nature Reviews Neuroscience, 2003 - nature.com
The endocannabinoids are a family of lipid messengers that engage the cell surface
receptors that are targeted by Δ9-tetrahydrocannabinol, the active principle in marijuana …

[HTML][HTML] A second endogenous cannabinoid that modulates long-term potentiation

N Stella, P Schweitzer, D Piomelli - Nature, 1997 - nature.com
Cannabinoid receptors are molecular targets for marijuana and hashish, the widespread
drugs of abuse. These receptors are expressed in areas of the central nervous system that …

[HTML][HTML] Role of endogenous cannabinoids in synaptic signaling

TF Freund, I Katona, D Piomelli - Physiological reviews, 2003 - journals.physiology.org
Freund, Tamás F., István Katona, and Daniele Piomelli. Role of Endogenous Cannabinoids
in Synaptic Signaling. Physiol Rev 83: 1017–1066, 2003; 10.1152/physrev. 00004.2003 …

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

G Marsicano, S Goodenough, K Monory, H Hermann… - Science, 2003 - science.org
Abnormally high spiking activity can damage neurons. Signaling systems to protect neurons
from the consequences of abnormal discharge activity have been postulated. We generated …

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

S Weggen, JL Eriksen, P Das, SA Sagi, R Wang… - Nature, 2001 - nature.com
Epidemiological studies have documented a reduced prevalence of Alzheimer's disease
among users of nonsteroidal anti-inflammatory drugs (NSAIDs),,,,. It has been proposed that …

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action

V Di Marzo, D Melck, T Bisogno, L De Petrocellis - Trends in neurosciences, 1998 - cell.com
The existence of an endogenous cannabinoid system was demonstrated conclusively with
the discovery of endogenous brain constituents capable of activating the cannabinoid …

Endocannabinoid-mediated synaptic plasticity in the CNS

V Chevaleyre, KA Takahashi, PE Castillo - Annu. Rev. Neurosci., 2006 - annualreviews.org
Abstract Changes in synaptic efficacy are thought to be crucial to experience-dependent
modifications of neural function. The diversity of mechanisms underlying these changes is …